The HER2 Phenotype of Circulating Tumor Cells in HER2-positive Early Breast Cancer: A Translational Research Project of a Prospective Randomized Phase III Trial

PLoS ONE - United States
doi 10.1371/journal.pone.0173593
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy® System in Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

The Impact of HER2 Phenotype of Circulating Tumor Cells in Metastatic Breast Cancer: A Retrospective Study in 107 Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Cancer
Cancer ResearchOncology
2018English

A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics
Genetics
2010English

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Optimizing the Management of HER2-positive Early Breast Cancer: The Clinical Reality

Current Oncology
Oncology
2010English

Efficacy and Safety of CT-P6 Versus Reference Trastuzumab in HER2-positive Early Breast Cancer: Updated Results of a Randomised Phase 3 Trial

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2019English

Dual HER2 Blockade Versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal of Oncology
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy